Aureon Biosciences Obtains $3,838,665 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0ae0631a-ccf7-472a-b82f-60ce324a5330&Preview=1 -
Date
9/30/2011 -
Company Name
Aureon Biosciences -
Mailing Address
28 Wells Avenue Yonkers, NY 10701 -
Company Description
Aureon Biosciences is a life science company founded in 2002, dedicated to enabling the advancement of predictive and personalized cancer treatment options. -
Website
http://www.aureon.com -
Transaction Type
Debt -
Transaction Amount
$3,838,665 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing-amended. -
M&A Terms
-
Venture Investor
Undisclosed
